NetraMark Holdings Inc. (TSX:AIAI)
Canada
· Delayed Price · Currency is CAD 0.900
-0.040 (-4.26%)
At close: Apr 28, 2026
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 118.85K CAD in the quarter ending December 31, 2025, a decrease of -69.22%. This brings the company's revenue in the last twelve months to 165.26K, down -80.37% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
165.26K
Revenue Growth
-80.37%
P/S Ratio
504.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
83.38M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hydreight Technologies | 24.48M |
| DIAGNOS | 68.16K |
| Principal Technologies | 370.42K |
| NexgenRx | 17.93M |
| Comprehensive Healthcare Systems | 5.79M |
| kneat.com | 63.26M |
| Vitalhub | 108.97M |
| AI/ML Innovations | 125.47K |
NetraMark Holdings News
- 7 days ago - NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs - GlobeNewsWire
- 9 days ago - Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory‑Grade Trial Design in Psychedelic Development - GlobeNewsWire
- 20 days ago - Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain - GlobeNewsWire
- 5 weeks ago - NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset - GlobeNewsWire
- 5 weeks ago - NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer's Trial at AD/PD Conference - GlobeNewsWire
- 7 weeks ago - NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data - GlobeNewsWire
- 2 months ago - NetraMark Closes Final Tranche of $3.5 Million Private Placement - GlobeNewsWire
- 2 months ago - CSE Bulletin: Delist - NetraMark Holdings Inc. (AIAI) - Newsfile Corp